Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.verified

ALXN

Price:

$182.5

Market Cap:

$0

Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS (eculizumab), a monoclonal antibody for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. In addition, the company is developing ALXN12...[Read more]

Industry

Biotechnology

IPO Date

1996-02-01

Stock Exchange

NASDAQ

Ticker

ALXN

The Current Ratio as of December 2025 (TTM) for Alexion Pharmaceuticals, Inc. (ALXN) is 3.59

According to Alexion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.59. This represents a change of -14.08% compared to the average of 4.18 of the last 4 quarters.

Alexion Pharmaceuticals, Inc. (ALXN) Historical Current Ratio (quarterly & annually)

How has ALXN Current Ratio performed in the past?

The mean historical Current Ratio of Alexion Pharmaceuticals, Inc. over the last ten years is 3.69. The current 3.59 Current Ratio has changed 9.62% with respect to the historical average. Over the past ten years (40 quarters), ALXN's Current Ratio was at its highest in in the March 2014 quarter at 5.66. The Current Ratio was at its lowest in in the March 2012 quarter at 2.30.

Quarterly (TTM)
Annual

Average

3.69

Median

3.67

Minimum

2.88

Maximum

4.61

Alexion Pharmaceuticals, Inc. (ALXN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alexion Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 47.42%

Maximum Annual Current Ratio = 4.61

Minimum Annual Increase = -26.72%

Minimum Annual Current Ratio = 2.88

Quarterly (TTM)
Annual
YearCurrent RatioChange
20203.59-15.54%
20194.2547.42%
20182.88-7.03%
20173.10-1.00%
20163.13-7.23%
20153.38-26.72%
20144.6122.73%
20133.75-9.60%
20124.151.59%
20114.09-12.41%

Alexion Pharmaceuticals, Inc. (ALXN) Average Current Ratio

How has ALXN Current Ratio performed in the past?

The current Current Ratio of Alexion Pharmaceuticals, Inc. (ALXN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

3.57

5-year avg

3.39

10-year avg

3.69

Alexion Pharmaceuticals, Inc. (ALXN) Current Ratio vs. Peers

How is ALXN’s Current Ratio compared to its peers?

Alexion Pharmaceuticals, Inc.’s Current Ratio is greater than Seagen Inc. (2.12), less than Ambrx Biopharma Inc. (5.44), less than Odonate Therapeutics, Inc. (111.72), less than La Jolla Pharmaceutical Company (3.82), less than Niagen Bioscience Inc (3.88), less than Roivant Sciences Ltd. (33.70), less than Takara Bio Inc. (4.93), less than Arena Pharmaceuticals, Inc. (8.59), less than EQRx, Inc. (27.51), less than POINT Biopharma Global Inc. (6.66),

Build a custom stock screener for Alexion Pharmaceuticals, Inc. (ALXN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alexion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alexion Pharmaceuticals, Inc. (ALXN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alexion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Alexion Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Alexion Pharmaceuticals, Inc. (ALXN)?

What is the highest Current Ratio for Alexion Pharmaceuticals, Inc. (ALXN)?

What is the 3-year average Current Ratio for Alexion Pharmaceuticals, Inc. (ALXN)?

What is the 5-year average Current Ratio for Alexion Pharmaceuticals, Inc. (ALXN)?

How does the current Current Ratio for Alexion Pharmaceuticals, Inc. (ALXN) compare to its historical average?